Buy & Sell ADMA Biologics Inc (ADMA) – ADMA Biologics Inc Price Today
Aura AI Summary
Key Stats
- $1.85BMarket Cap
- HealthSector
- -52.94%3M Drawdown
- $1.91BEnterprise Value
- -Dividend Yield
- 10 daysTypical Hold Time
ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $1.85B, with an enterprise value of $1.91B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.6 and a high of $21.87, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -52.94%, reflecting recent price volatility. On average, investors hold ADMA Biologics Inc for approximately 10 days, indicating typical investor behavior on the platform.
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Most Recent News
Nvidia signs deal with SK Hynix but South Korean chip stocks fall sharply amid AI trade slowdown
Nvidia CEO Jensen Huang signed a new partnership agreement with South Korean memory-chip maker SK Hynix. Despite this, shares of SK Hynix and Samsung Electronics dropped over 10% each, reflecting investor concerns amid a cooling AI trade. South Korea...

NVIDIA and SK hynix partner to develop AI memory tech, boosting Korean tech amid chip selloff.
NVIDIA and SK hynix announced a multiyear partnership to co-develop next-generation memory for AI systems, including NVIDIA's Vera Rubin supercomputers and other AI platforms. This deal aims to strengthen Korea's tech sector during a global chip mark...

Tyson Foods beats Q2 estimates, raises 2026 cash flow forecast, keeps Buy rating despite risks.
Tyson Foods reported strong Q2 results, surpassing sales and earnings expectations, and raised its free cash flow guidance for fiscal year 2026 to between $1.2 and $1.8 billion. The company also reduced its total debt by $747 million, strengthening i...
